Clinical Trial Update: To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating the safety and efficacy of STSA-1002 injection in patients with acute respiratory distress syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• STSA-1002

Snippet

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd | Conditions: Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Status: RECRUITING